MRNS
Adage Capital Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,331,250
| Closed | -$21.1M | – | 964 |
|
|
2024
Q1 | $21.1M | Sell |
2,331,250
-250,000
| -10% | -$2.26M | 0.04% | 437 |
|
|
2023
Q4 | $28.1M | Sell |
2,581,250
-323,226
| -11% | -$3.51M | 0.06% | 336 |
|
|
2023
Q3 | $23.4M | Buy |
2,904,476
+173,226
| +6% | +$1.39M | 0.05% | 347 |
|
|
2023
Q2 | $29.7M | Buy |
2,731,250
+696,750
| +34% | +$7.57M | 0.06% | 301 |
|
|
2023
Q1 | $14M | Sell |
2,034,500
-18,000
| -0.9% | -$124K | 0.03% | 532 |
|
|
2022
Q4 | $8.17M | Buy |
2,052,500
+815,000
| +66% | +$3.24M | 0.02% | 684 |
|
|
2022
Q3 | $8.23M | Sell |
1,237,500
-25,000
| -2% | -$166K | 0.02% | 688 |
|
|
2022
Q2 | $6.11M | Hold |
1,262,500
| – | – | 0.01% | 777 |
|
|
2022
Q1 | $11.8M | Hold |
1,262,500
| – | – | 0.02% | 650 |
|
|
2021
Q4 | $15M | Hold |
1,262,500
| – | – | 0.03% | 582 |
|
|
2021
Q3 | $14.4M | Hold |
1,262,500
| – | – | 0.03% | 584 |
|
|
2021
Q2 | $22.6M | Sell |
1,262,500
-200,000
| -14% | -$3.59M | 0.04% | 418 |
|
|
2021
Q1 | $22.6M | Hold |
1,462,500
| – | – | 0.05% | 407 |
|
|
2020
Q4 | $17.8M | Hold |
1,462,500
| – | – | 0.04% | 440 |
|
|
2020
Q3 | $18.8M | Sell |
1,462,500
-4,837,500
| -77% | -$62.2M | 0.05% | 393 |
|
|
2020
Q2 | $16M | Buy |
6,300,000
+1,500,000
| +31% | +$3.81M | 0.04% | 439 |
|
|
2020
Q1 | $9.74M | Hold |
4,800,000
| – | – | 0.03% | 474 |
|
|
2019
Q4 | $10.4M | Buy |
+4,800,000
| New | +$10.4M | 0.03% | 531 |
|
|
2018
Q1 | – | Sell |
-567,000
| Closed | -$4.63M | – | 773 |
|
|
2017
Q4 | $4.63M | Sell |
567,000
-33,000
| -6% | -$269K | 0.01% | 633 |
|
|
2017
Q3 | $3.52M | Buy |
+600,000
| New | +$3.52M | 0.01% | 646 |
|